Target identification and mechanism of action in chemical biology and drug discovery.
暂无分享,去创建一个
[1] C. Anfinsen,et al. Selective enzyme purification by affinity chromatography. , 1968, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Yoshida,et al. Effects of trichostatins on differentiation of murine erythroleukemia cells. , 1987, Cancer research.
[3] D A Scudiero,et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.
[4] S. Schreiber,et al. A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.
[5] S. Schreiber,et al. The mechanism of action of cyclosporin A and FK506. , 1992, Immunology today.
[6] Jun O. Liu,et al. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. , 1992, Biochemistry.
[7] Stuart L. Schreiber,et al. A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.
[8] T. Mitchison,et al. Towards a pharmacological genetics. , 1994, Chemistry & biology.
[9] David M. Rocke,et al. Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.
[10] S. Schreiber,et al. A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.
[11] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[12] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[13] S. Schreiber. Chemical genetics resulting from a passion for synthetic organic chemistry. , 1998, Bioorganic & medicinal chemistry.
[14] Steven L. Dixon,et al. Bioactive Diversity and Screening Library Selection via Affinity Fingerprinting , 1998, J. Chem. Inf. Comput. Sci..
[15] P. Brown,et al. Drug target validation and identification of secondary drug target effects using DNA microarrays , 1998, Nature Medicine.
[16] L Meijer,et al. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. , 1999, Cancer research.
[17] S. Gygi,et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.
[18] Yudong D. He,et al. Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.
[19] B. Stockwell. Chemical genetics: ligand-based discovery of gene function , 2000, Nature Reviews Genetics.
[20] S A Sundberg,et al. High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. , 2000, Current opinion in biotechnology.
[21] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[22] Ruedi Aebersold,et al. The study of macromolecular complexes by quantitative proteomics , 2003, Nature Genetics.
[23] Blagoy Blagoev,et al. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling , 2003, Nature Biotechnology.
[24] Shu-Hui Chen,et al. Stable-isotope dimethyl labeling for quantitative proteomics. , 2003, Analytical chemistry.
[25] Andrew H. Thompson,et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.
[26] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[27] Tae-Wook Kang,et al. Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. , 2003, Journal of the American Chemical Society.
[28] Yoshiya Oda,et al. Quantitative chemical proteomics for identifying candidate drug targets. , 2003, Analytical chemistry.
[29] Norbert Perrimon,et al. Parallel Chemical Genetic and Genome-Wide RNAi Screens Identify Cytokinesis Inhibitors and Targets , 2004, PLoS biology.
[30] L. Burdine,et al. Target identification in chemical genetics: the (often) missing link. , 2004, Chemistry & biology.
[31] Grant W. Brown,et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways , 2004, Nature Biotechnology.
[32] D. Brehmer,et al. Proteome-wide Identification of Cellular Targets Affected by Bisindolylmaleimide-type Protein Kinase C Inhibitors* , 2004, Molecular & Cellular Proteomics.
[33] M. Cotten,et al. Chemical Proteomic Analysis Reveals Alternative Modes of Action for Pyrido[2,3-d]pyrimidine Kinase Inhibitors* , 2004, Molecular & Cellular Proteomics.
[34] T. Terada,et al. Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins. , 2004, Bioorganic & medicinal chemistry.
[35] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[36] B. Stockwell. Exploring biology with small organic molecules , 2004, Nature.
[37] Xiaofeng S Zheng,et al. Genetic and genomic approaches to identify and study the targets of bioactive small molecules. , 2004, Chemistry & biology.
[38] Lani F. Wu,et al. Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.
[39] Todd R Golub,et al. Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation , 2004, Nature Genetics.
[40] Paul A Clemons,et al. Complex phenotypic assays in high-throughput screening. , 2004, Current opinion in chemical biology.
[41] Paul A Clemons,et al. Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space. , 2004, Journal of the American Chemical Society.
[42] A. Heck,et al. Development of a Novel Chemical Probe for the Selective Enrichment of Phosphorylated Serine‐ and Threonine‐Containing Peptides , 2005, Chembiochem : a European journal of chemical biology.
[43] D. Bojanic,et al. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. , 2005, Drug discovery today.
[44] M. Mann,et al. Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.
[45] B. Cravatt,et al. A tandem orthogonal proteolysis strategy for high-content chemical proteomics. , 2005, Journal of the American Chemical Society.
[46] M. Fielden,et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.
[47] L. Wodicka,et al. A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.
[48] K. Anderson,et al. Analysis of mouse embryonic patterning and morphogenesis by forward genetics , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] A. Saghatelian,et al. Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling , 2005, Nature Biotechnology.
[50] Lin Tang,et al. Roscovitine Targets, Protein Kinases and Pyridoxal Kinase*[boxs] , 2005, Journal of Biological Chemistry.
[51] J. N. Kay,et al. Forward Genetic Analysis of Visual Behavior in Zebrafish , 2005, PLoS genetics.
[52] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[53] A. Fliri,et al. Biological spectra analysis: Linking biological activity profiles to molecular structure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[54] Eric J Kunkel,et al. Characterization of compound mechanisms and secondary activities by BioMAP analysis. , 2006, Journal of pharmacological and toxicological methods.
[55] Meir Glick,et al. Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..
[56] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[57] Eric W. Klee,et al. Genome-Wide Reverse Genetics Framework to Identify Novel Functions of the Vertebrate Secretome , 2006, PloS one.
[58] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[59] Anne E Carpenter,et al. A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen , 2006, Cell.
[60] D. Guertin,et al. Functional Genomics Identifies TOR-Regulated Genes that Control Growth and Division , 2006, Current Biology.
[61] T. Golub,et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.
[62] Corey Nislow,et al. A unique and universal molecular barcode array , 2006, Nature Methods.
[63] H. Schöler,et al. Self-renewal of embryonic stem cells by a small molecule , 2006, Proceedings of the National Academy of Sciences.
[64] S. Haggarty,et al. Revealing complex traits with small molecules and naturally recombinant yeast strains. , 2006, Chemistry & biology.
[65] M. Bogyo,et al. A mild chemically cleavable linker system for functional proteomic applications. , 2007, Angewandte Chemie.
[66] Christopher P Austin,et al. High-throughput screening assays for the identification of chemical probes. , 2007, Nature chemical biology.
[67] G. Terstappen,et al. Target deconvolution strategies in drug discovery , 2007, Nature Reviews Drug Discovery.
[68] Minoru Yoshida,et al. [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. , 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[69] Stuart L Schreiber,et al. Genetic basis of individual differences in the response to small-molecule drugs in yeast , 2007, Nature Genetics.
[70] A. Tanaka. [A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[71] Dennis B. Troup,et al. NCBI GEO: mining tens of millions of expression profiles—database and tools update , 2006, Nucleic Acids Res..
[72] Anne E Carpenter. Image-based chemical screening. , 2007, Nature chemical biology.
[73] Bernhard Kuster,et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.
[74] Young-Tae Chang,et al. Tagged library approach facilitates forward chemical genetics. , 2007, Molecular bioSystems.
[75] M. Bogyo,et al. Proteomics Evaluation of Chemically Cleavable Activity-based Probes* , 2007, Molecular & Cellular Proteomics.
[76] Xiaodong Wang,et al. Diazonamide toxins reveal an unexpected function for ornithine δ-amino transferase in mitotic cell division , 2007, Proceedings of the National Academy of Sciences.
[77] K. Shokat,et al. Chemical Genetics: Where Genetics and Pharmacology Meet , 2007, Cell.
[78] Heng Zhu,et al. Applications of protein microarray technology. , 2007, Combinatorial chemistry & high throughput screening.
[79] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[80] Martin Serrano,et al. Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .
[81] Stephen T. C. Wong,et al. Cellular Phenotype Recognition for High-Content RNA Interference Genome-Wide Screening , 2008, Journal of biomolecular screening.
[82] Peter G. Schultz,et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen , 2008, Proceedings of the National Academy of Sciences.
[83] Frank E Koehn,et al. High impact technologies for natural products screening. , 2008, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[84] B. Doble,et al. Prevention of Amino Acid Conversion in SILAC Experiments with Embryonic Stem Cells * , 2008, Molecular & Cellular Proteomics.
[85] Michael Boutros,et al. The art and design of genetic screens: RNA interference , 2008, Nature Reviews Genetics.
[86] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[87] John A. Tallarico,et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. , 2008, Nature chemical biology.
[88] M. Mann,et al. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. , 2008, Molecular cell.
[89] Stuart L. Schreiber,et al. Towards the Optimal Screening Collection: A Synthesis Strategy. , 2008 .
[90] Makoto Muroi,et al. The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I , 2008, Proceedings of the National Academy of Sciences.
[91] K. Shokat,et al. Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases , 2008, Nature chemical biology.
[92] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[93] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[94] R. Sinden,et al. Reverse genetics screen identifies six proteins important for malaria development in the mosquito , 2008, Molecular microbiology.
[95] Paul A Clemons,et al. Connecting synthetic chemistry decisions to cell and genome biology using small-molecule phenotypic profiling. , 2009, Current opinion in chemical biology.
[96] Yanli Wang,et al. PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..
[97] Wen-Lian Hsu,et al. MaXIC-Q Web: a fully automated web service using statistical and computational methods for protein quantitation based on stable isotope labeling and LC–MS , 2009, Nucleic Acids Res..
[98] John A. Tallarico,et al. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds , 2009, Nature Reviews Drug Discovery.
[99] G. Superti-Furga,et al. Target profiling of small molecules by chemical proteomics. , 2009, Nature chemical biology.
[100] Reinout Raijmakers,et al. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics , 2009, Nature Protocols.
[101] R. Higgs,et al. Capture of drug targets from live cells using a multipurpose immuno-chemo-proteomics tool. , 2009, Journal of proteome research.
[102] Bin Chen,et al. PubChem as a Source of Polypharmacology , 2009, J. Chem. Inf. Model..
[103] T. Golub,et al. Empirical Bayes Analysis of Quantitative Proteomics Experiments , 2009, PloS one.
[104] Steven A Carr,et al. Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.
[105] Lorenz M Mayr,et al. Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.
[106] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[107] Paul A. Clemons,et al. Using biological performance similarity to inform disaccharide library design. , 2009, Journal of the American Chemical Society.
[108] K. Shokat,et al. Targeting the cancer kinome through polypharmacology , 2010, Nature Reviews Cancer.
[109] Toshihiko Ogura,et al. Identification of a Primary Target of Thalidomide Teratogenicity , 2010, Science.
[110] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[111] Joshua A. Bittker,et al. Small-molecule inducers of insulin expression in pancreatic α-cells , 2010, Proceedings of the National Academy of Sciences.
[112] Ravi Iyengar,et al. Systems pharmacology. , 2010, The Mount Sinai journal of medicine, New York.
[113] K. Chou,et al. Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.
[114] Brett R. Murphy,et al. Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound. , 2010, Chemistry & biology.
[115] Anne E Carpenter,et al. Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis , 2010, Nature chemical biology.
[116] M. Mann,et al. MSQuant, an open source platform for mass spectrometry-based quantitative proteomics. , 2010, Journal of proteome research.
[117] T. Muchamuel,et al. Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events , 2011, Clinical Cancer Research.
[118] D. Bojanic,et al. Impact of high-throughput screening in biomedical research , 2011, Nature Reviews Drug Discovery.
[119] Dana Pe'er,et al. Modulatory profiling identifies mechanisms of small molecule-induced cell death , 2011, Proceedings of the National Academy of Sciences.
[120] Lei Xie,et al. Structure-based systems biology for analyzing off-target binding. , 2011, Current opinion in structural biology.
[121] Jeremy R. Duvall,et al. AAK1 identified as an inhibitor of neuregulin-1/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomics. , 2011, Chemistry & biology.
[122] Andreas Bender,et al. From in silico target prediction to multi-target drug design: current databases, methods and applications. , 2011, Journal of proteomics.
[123] R. Olsen,et al. Identification of Direct Protein Targets of Small Molecules , 2010, ACS chemical biology.
[124] Ian H Gilbert,et al. Target Validation: Linking Target and Chemical Properties to Desired Product Profile , 2011, Current topics in medicinal chemistry.
[125] Bryan L. Roth,et al. Chemical Informatics and Target Identification in a Zebrafish Phenotypic Screen , 2011, Nature chemical biology.
[126] E. Winzeler,et al. Target identification and validation of novel antimalarials. , 2011, Future microbiology.
[127] M. Mann,et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.
[128] Michael Schroeder,et al. Old friends in new guise: repositioning of known drugs with structural bioinformatics , 2011, Briefings Bioinform..
[129] D. Swinney,et al. How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.
[130] D R Mani,et al. iTRAQ Labeling is Superior to mTRAQ for Quantitative Global Proteomics and Phosphoproteomics* , 2011, Molecular & Cellular Proteomics.
[131] Yanli Wang,et al. Identifying Compound-Target Associations by Combining Bioactivity Profile Similarity Search and Public Databases Mining , 2011, J. Chem. Inf. Model..
[132] Peter S. Kutchukian,et al. Rethinking molecular similarity: comparing compounds on the basis of biological activity. , 2012, ACS chemical biology.
[133] Anne E Carpenter,et al. Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL , 2012, Cell.
[134] Forest M White,et al. Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML. , 2012, Nature chemical biology.
[135] Olivier Elemento,et al. Using transcriptome sequencing to identify mechanisms of drug action and resistance , 2011, Nature chemical biology.
[136] B. Cravatt,et al. Fully functionalized small-molecule probes for integrated phenotypic screening and target identification. , 2012, Journal of the American Chemical Society.
[137] Peter C. St. John,et al. Identification of Small Molecule Activators of Cryptochrome , 2012, Science.
[138] Jongmin Park,et al. Discovery and target identification of an antiproliferative agent in live cells using fluorescence difference in two-dimensional gel electrophoresis. , 2012, Angewandte Chemie.
[139] David R Spring,et al. Diversity-oriented synthesis: producing chemical tools for dissecting biology. , 2012, Chemical Society reviews.
[140] A. Dopazo,et al. Identification of disease-relevant genes for molecularly-targeted drug discovery. , 2012, Current cancer drug targets.
[141] A. Emili,et al. Target Identification by Chromatographic Co-elution: Monitoring of Drug-Protein Interactions without Immobilization or Chemical Derivatization* , 2012, Molecular & Cellular Proteomics.
[142] David R. Spring,et al. Diversity-Oriented Synthesis: Producing Chemical Tools for Dissecting Biology , 2012 .
[143] Selective killing of cancer cells by a small molecule targeting the stress response to ROS , 2012, Nature.
[144] J. Irwin,et al. Identifying mechanism-of-action targets for drugs and probes , 2012, Proceedings of the National Academy of Sciences.
[145] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[146] Stefan Wetzel,et al. Charting, navigating, and populating natural product chemical space for drug discovery. , 2012, Journal of medicinal chemistry.
[147] Chee Keong Kwoh,et al. Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..
[148] Charles Boone,et al. Systems-level antimicrobial drug and drug synergy discovery. , 2013, Nature chemical biology.